scispace - formally typeset
J

Julia Slotta-Huspenina

Researcher at Technische Universität München

Publications -  146
Citations -  10859

Julia Slotta-Huspenina is an academic researcher from Technische Universität München. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 36, co-authored 124 publications receiving 7901 citations. Previous affiliations of Julia Slotta-Huspenina include Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Mass-spectrometry-based draft of the human proteome

TL;DR: A mass-spectrometry-based draft of the human proteome and a public, high-performance, in-memory database for real-time analysis of terabytes of big data, called ProteomicsDB are presented, which enables navigation of proteomes, provides biological insight and fosters the development of proteomic technology.
Journal ArticleDOI

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A Hoadley, +738 more
- 05 Apr 2018 - 
TL;DR: Molecular similarities among histologically or anatomically related cancer types provide a basis for focused pan-cancer analyses, such as pan-gastrointestinal, Pan-gynecological, pan-kidney, and pan-squamous cancers, and those related by stemness features, which may inform strategies for future therapeutic development.
Journal ArticleDOI

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Benjamin J. Raphael, +265 more
- 14 Aug 2017 - 
TL;DR: An integrated multi-platform analysis of 150 pancreatic ductal adenocarcinoma specimens reveals a complex molecular landscape of PDAC and provides a roadmap for precision medicine.
Journal ArticleDOI

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor, +732 more
- 09 Apr 2018 - 
TL;DR: The genomic and phenotypic correlates of cancer aneuploidy are defined and genome engineering is applied to delete 3p in lung cells, causing decreased proliferation rescued in part by chromosome 3 duplication.
Journal ArticleDOI

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis

TL;DR: Exposure of human colorectal cancer cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron, indicating that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL- 6R/STAT3/miR- 34a feedback loop.